NLRP3 and viral pneumonia: These natural molecules can synergistically block the initiation and cascade of NLRP3 inflammasome through multi-target synergistic blocking in viral pneumonia models, providing a solid experimental basis for the development of adjuvant therapy strategies with broad-spectrum immunomodulatory effects.